Trim 15-20% SPCX exposure at $147-148; front-load execution; anchor residual stop at $141.97
Underweight justified by four converging headwinds: 50 SMA below 200 SMA confirming recovery not uptrend, $47.2B unlock overhang with second tranche ahead, mathematically certain stop-loss clipping ($2.19 stop vs $7.65 ATR), and capital rotation risk from mid-October Anthropic IPO. 15-20% trim calibrated to 9/04 SPCX reflection which explicitly states trim size at stretched multiples should default toward conservative end of analyst range, not scale inversely to the multiple. Reject both Aggressive Analyst's full SELL (ignores 8/14 binding reflection and auditable Q2 fundamentals) and Conservative Analyst's pure Hold (replicates 9/01-9/02 failure patterns). Institutional floor ($108-130 zone absorbed multiple tests) precludes full exit, supporting residual position with disciplined stop management.
| Position | Action |
|---|---|
| at $147-148 (current levels) | Trim 15-20% of SPCX exposure, front-loaded execution |
| residual position post-trim | Anchor stop at $141.97 (200 SMA) with confirmed-close condition, not intraday |
| rejected: covered call hedge | 15-20% trim achieves same gross exposure reduction without bid-ask spread risk or upside cap |
| rejected: contingent trim at $152 | Front-load trim per NFLX 9/03 cross-ticker lesson; catalyst proximity overrides structural elegance |
SPCX presents a asymmetric buy-the-dip setup where the $47.2 billion unlock risk is fully priced in, smart money is accumulating, and the company is inflectioning from growth-stage burn to operating leverage with Q2 2026 revenue up 91.9% YoY and EBITDA turning positive at $2.96 billion.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | $145.36 | bullish |
| close_50_sma | $135.65 | bullish |
| close_200_sma | $141.97 | bullish |
| macd | 4.18 | bullish |
| macds | 3.18 | bullish |
| rsi | 56.40 | bullish |
| boll_ub | $152.32 | neutral |
| atr | $7.65 | neutral |
Support: 145.36 · 141.97 · 139.9 · 136.08 · 135.65 | Resistance: 152.32 · 153.47 · 153
SPCX has a moderately bullish but volatile technical profile with the close at $147.55 above the 10-day EMA ($145.36), 50-day SMA ($135.65), and 200-day SMA ($141.97). MACD remains positive at 4.18 with signal at 3.18, and RSI is neutral-to-bullish at 56.40, indicating room for upside without overbought conditions. The stock is approaching the upper Bollinger Band at $152.32, creating elevated chase risk if entering immediately. ATR of $7.65 represents high volatility requiring ATR-adjusted stops, with risk references at approximately $139.90 (one ATR below) and $136.08 (1.5 ATR below). The 50-day SMA remains below the 200-day SMA, indicating incomplete moving-average confirmation for a fully established uptrend. Rating: HOLD.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 30-45 day horizon
Then: Reassess after Q3 2026 earnings, September FOMC, second tranche absorption/distribution, Starship Flight 14 outcome
The insider unlock was a calendar-known event — bad news already absorbed at 4–5% drop
↩ rebuts: “Bear's fear of $47.2 billion insider overhang creating sustained selling pressure”
EV: Target at upper Bollinger Band ($152.32); longer-term thesis toward $225 highs over 12–18 months · concedes: Bear thesis is factually correct that the unlock was a large, calendar-known event; Forward P/E of 88x is genuinely elevated — not disputed; Negative TTM FCF is real, though positioned as strategic investment rather than distress; Recession odds of 8% and Fed on hold create some headwinds for growth valuations
SPCX is in a structural distribution event, not a dip—facing $47B+ insider supply pressure, 88x forward P/E at negative operating margins, 50/200 SMA bearish configuration, and near-term catalysts that contradict the bull's "smart money" thesis.
· concedes: $100B cash pile is the bull's strongest point and real; +92% YoY revenue growth in Q2 2026 is real; +820bps gross margin expansion in two years is real; $4.1B EBITDA swing from Q1 to Q2 is real data (though argued to be noise, not inflection); Reddit pre-unlock euphoria on Sept 2, 4, 8 is observable data (though post-unlock observation is absent)
→ vs conservative: Correctly identified unlock overhang, elevated ATR, 50-day below 200-day SMA, supply risk, and macro headwinds but recommended HOLD — refused to act on bearish signals they documented
→ vs neutral: Recommended HOLD with tactical sell-the-rip bias despite acknowledging every input (unlock, distribution, sector contagion, Fed hawkishness, Anthropic rotation risk) is bearish — this is 'a wish, not a thesis'
→ vs neutral: Cited billionaire accumulation from Q2 as bullish counterweight but Q2 positions built at sub-$130 levels are ancient history during an active unlock event; smart money likely reducing exposure into unlock as exit liquidity
→ vs neutral: Referenced Polymarket 38% SPCX versus 60% Anthropic as 'neutral-bullish scarcity premium' but failed to connect Anthropic's mid-October IPO to capital rotation warning that demands a SELL call
Market Cap
$1,944,971,640,832
Forward P/E
88.32x
Price/Book
15.28x
EPS (TTM)
-$1.10
Forward EPS
$1.67
Book Value/Share
$9.66
52-Week High
$225.64
52-Week Low
$104.83
50-Day MA
$135.99
200-Day MA
$141.88
Q2 2026 Revenue
$7,814M
Q2 2026 Gross Profit
$4,319M
Q2 2026 Gross Margin
55.3%
Q2 2026 R&D Expense
$3,548M
Q2 2026 Operating Income
-$141M
Q2 2026 Operating Margin
-1.8%
Q2 2026 EBITDA
$2,959M
Q2 2026 Net Income
-$541M
Q2 2026 Diluted EPS
-$0.09
FY 2025 Revenue
$18,674M
FY 2025 Revenue YoY Growth
+33.2%
FY 2025 Gross Margin
49.4%
FY 2025 R&D Expense
$8,643M
FY 2025 Operating Income
-$2,064M
FY 2025 Operating Margin
-11.1%
FY 2025 EBITDA
$4,427M
FY 2025 Net Income
-$4,937M
FY 2025 Diluted EPS
-$0.51
FY 2025 D&A
$6,701M
FY 2024 Revenue
$14,015M
FY 2024 Revenue YoY Growth
+34.9%
FY 2024 Gross Margin
42.9%
FY 2024 Operating Income
$742M
FY 2024 Operating Margin
+5.3%
FY 2024 Net Income
$791M
FY 2023 Revenue
$10,387M
FY 2023 Gross Margin
41.2%
FY 2023 Net Income
-$4,628M
Q2 2026 Cash & ST Investments
$100,009M
Q2 2026 Total Assets
$192,770M
Q2 2026 Total Debt
$39,708M
Q2 2026 Stockholders' Equity
$127,224M
Q2 2026 Net PPE
$66,854M
Q2 2026 Construction in Progress
$12,554M
Q2 2026 Working Capital
$86,925M
Q2 2026 Current Ratio
5.1x
Q2 2026 Deferred Revenue
$14,300M
Q2 2026 Operating Cash Flow
$2,419M
Q2 2026 CapEx
-$19,238M
Q2 2026 Free Cash Flow
-$16,819M
Q2 2026 Stock Issuance
$85,675M
FY 2025 Operating Cash Flow
$6,785M
FY 2025 CapEx
-$20,906M
FY 2025 Free Cash Flow
-$14,121M
FY 2024 Free Cash Flow
-$5,387M
FY 2023 Free Cash Flow
+$105M
TTM Revenue
$23.0B
TTM Gross Profit
$11.95B
TTM EBITDA
$5.90B
TTM Net Income
-$8.89B
TTM Profit Margin
-35.7%
TTM Operating Cash Flow
~$8.2B
TTM CapEx
~$39B
TTM Free Cash Flow
~-$30B
H1 2026 Free Cash Flow
-$25,886M
FY 2023-25 Revenue CAGR
~34%
Diluted Share Count Q1 2026
~10.6B
Diluted Share Count Q2 2026
~5.86B
Strengths
Concerns
SPCX is a recently-public mega-cap aerospace company (~$1.945T market cap) demonstrating strong top-line momentum with 91.9% YoY revenue growth in Q2 2026 and expanding gross margins (41.2% to 55.3% over three years), but remains deeply unprofitable on a net income basis (-$8.89B TTM) due to explosive R&D ($8.6B in FY2025) and CapEx ($50B+ annualized run-rate) spending. The company's $100B post-IPO cash position provides substantial liquidity runway, though the 88x forward P/E valuation and negative free cash flow of roughly -$30B TTM represent significant risk if execution disappoints.
Macro: The macro backdrop is firmly hawkish with the Fed priced as on hold through 2026—December cut odds fell 3pp to just 6% this week while recession odds sit at a low 8%. Rising oil prices and Treasury yields are pressuring growth multiples broadly, with Charles Schwab client data showing investors dialing back risk in August. The risk-reward for SPCX is complicated by an approaching IPO stampede (Anthropic targeting mid-October launch) that could be both a liquidity event for peers and a competing-narrative risk. Fed policy data from FRED was unavailable due to API key absence, but directional read is higher-for-longer with oil/yield complex as the primary growth-multiple headwind.